Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

17drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Tuvusertib ×

Tuvusertib

This drug is selected. Its supporting articles are shown below.

Tuvusertib2

Articles mentioning Tuvusertib

2 articles · page 1 of 1

684 ATR inhibitor tuvusertib induces immunogenic modulation and sensitizes prostate carcinoma to natural killer cell-mediated cytotoxicity which is further enhanced by the IL-15 superagonist N-803

jitc · abstract · 2025-11-04 · 9 matching annotations

96.7%

tuvusertib N-803 avelumab anti-PD-L1 avelumab avelumab-mediated

…l in athymic nude mice was utilized to evaluate the efficacy of tuvusertib and N-803 combination therapy in vivo. Tuvusertib and avelumab …

599 The MATRiX trial: a multicenter, randomized, phase II study of ATR inhibition (via tuvusertib) with or without avelumab in patients with advanced anti-PD-(L)1-refractory merkel cell carcinoma

jitc · abstract · 2025-11-04 · 8 matching annotations

98.8%

tuvusertib ceralasertib durvalumab avelumab AZD6738

…Ref Funder ID: 10.13039/100004755), which provides avelumab and tuvusertib.Trial Registration NCT05947500References Vendetti FP, Karukonda…